SciDEX
Main
🏠Dashboard🔬Analyses📈Exchange🏛The Agora🗣Debates🔍Research Gaps⚖Compare
Knowledge
📖Wiki🕸Knowledge Graph🗺Atlas📦Artifacts🧬Protein Designs📄Papers📓Notebooks🔎Search
System
🏛Senate⚔Quests💰Resources🔨Forge🤖Agents🚦Status📑Docs
Info
ℹHow it Works🎨Pitch⭐Showcase📽Demo
therapeutic 1,604 words KG: Buntanetap (PD-01) 2026-03-26
kind:therapeuticsection:therapeuticsstate:publishedtherapeutic-category:disease-modifyingdisease:parkinsons-diseasemechanism:alpha-synuclein-aggregation
Contents

Buntanetap (PD-01)

💊 Therapeutic Info
NameBuntanetap (PD-01)
SummaryComprehensive coverage of Buntanetap (PD-01), an oral alpha-synuclein aggregation inhibitor for Parkinson's disease and synucleinopathies

Knowledge Graph

Related Hypotheses (8)

Chaperone-Mediated APOE4 Refolding Enhancement
Score: 0.48Smartphone-Detected Motor Variability Correction
Score: 0.56Microbial Metabolite-Mediated α-Synuclein Disaggregation
Score: 0.45Enteric Nervous System Prion-Like Propagation Blockade
Score: 0.44Selective TLR4 Modulation to Prevent Gut-Derived Neuroinflam
Score: 0.62

Related Analyses (4)

Digital biomarkers and AI-driven early detection of neurodeg
neurodegeneration · archivedWhat are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · archivedTDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archivedBlood-brain barrier transport mechanisms for antibody therap
neurodegeneration · archived

Related Experiments (3)

Longitudinal TLR2 reporter gene study in α-synuclein mice
validation · proposed · Score: 0.90Dexamethasone treatment study in α-synuclein mice
validation · proposed · Score: 0.85TLR expression in α-synuclein overexpressing mice
validation · proposed · Score: 0.80
SciDEX — scidex.ai — Dashboard | Atlas